儿童及青年B细胞急性淋巴细胞白血病增强风险分层:儿童肿瘤协作组报告
研究基于21199例患者开发并验证多变量Cox模型用于无复发生存,构建COG预后指数(PICOG)并确定最佳截断值以区分复发风险。PICOG可可靠区分低与高复发风险患者,在现行COG中危组中识别出5年RFS不同的亚组,在标危平均风险组中识别出RFS为96%和90%的低危和中危组,在高危组中识别出RFS从96%到66%的四组,提供额外区分。与原有算法联合可更准确分层,识别预后较好可能受益于减轻治疗的患者及高复发风险需创新治愈手段的患者。
要点
- PICOG基于21199例患者的多变量Cox模型构建,可区分儿童及青年B-ALL的复发风险。
- 现行COG标危平均风险组中,PICOG识别出5年RFS为96%和90%的低危和中危亚组。
- 现行COG高危组中,PICOG识别出5年RFS从96%到66%的四组,提供额外区分。
核心结论
- PICOG与原有算法联合可更准确进行风险分层,识别预后较好可能受益于减轻治疗的患者及高复发风险需创新治愈手段的患者。
研究设计与样本
- 开发并验证多变量Cox模型用于无复发生存(RFS),使用21199例患者信息构建COG预后指数(PICOG)并确定最佳截断值以最大化预测模型区分度。
主要发现
- PICOG较高的患者预测复发风险较高,PICOG可可靠区分低与高复发风险患者。
- 在现行COG风险分类中具有中等复发风险的患者中,PICOG识别出5年RFS不同的亚组。
- 现行COG标危平均风险组中,PICOG识别出低危和中危组,5年RFS分别为96%和90%。
- 现行COG高危患者中,PICOG识别出四组,5年RFS从96%到66%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Current strategies to treat pediatric acute lymphoblastic leukemia rely on risk stratification algorithms using categorical data. We investigated whether using continuous variables assigned different weights would improve risk stratification. We developed and validated a multivariable Cox model for relapse-free survival (RFS) using information from 21199 patients. We constructed risk groups by identifying cutoffs of the COG Prognostic Index (PICOG) that maximized discrimination of the predictive model. Patients with higher PICOG have higher predicted relapse risk. The PICOG reliably discriminates patients with low vs. high relapse risk. For those with moderate relapse risk using current COG risk classification, the PICOG identifies subgroups with varying 5-year RFS. Among current COG standard-risk average patients, PICOG identifies low and intermediate risk groups with 96% and 90% RFS, respectively. Similarly, amongst current COG high-risk patients, PICOG identifies four groups ranging from 96% to 66% RFS, providing additional discrimination for future treatment stratification. When coupled with traditional algorithms, the novel PICOG can more accurately risk stratify patients, identifying groups with better outcomes who may benefit from less intensive therapy, and those who have high relapse risk needing innovative approaches for cure.
引用
- DelRocco NJ, Loh ML, Borowitz MJ, et al. Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report. Leukemia. 2024. PMID: 38360863. doi:10.1038/s41375-024-02166-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。